Company news
Bloomage Biotechnology Corp. Ltd. Class A (SSE:688363) news
Bloomage Biotechnology Corp. Ltd. Class A news releases on 6ix. Latest, Nov 30, 2024: Announcement on Convening the Q3 2024 Performance Briefing
Press releases — page 2
Announcement on Convening the Q3 2024 Performance Briefing
November 29, 2024
Notice on Convening the 1st Extraordinary General Meeting in 2024
November 15, 2024
Indicative Announcement on Shareholders with Over 5% Reducing Shares by 1%
November 11, 2024
Announcement on Resolutions of the 15th Meeting of the 2nd Board of Directors
October 30, 2024
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
October 29, 2024
Announcement on Plan of Shareholding Reduction by Shareholders
October 8, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 20, 2024
Announcement on Expiration of the Term and Implementation Results of Repurchasing Shares
August 29, 2024
Special Report on Semi-annual Storage and Actual Use of Raised Funds in 2024
August 23, 2024
Announcement on Progress in Repurchasing Shares through Call Auction
August 1, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 28, 2024
Notice on Convening 2023 Annual General Meeting
June 7, 2024
Announcement on Formulating and Amending Some Detailed Rules of Governance Systems
June 6, 2024
Announcement on Progress in Repurchasing Shares through Auction
May 31, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
May 29, 2024
Announcement on Concluding Some Investment Projects Financed by Raised Funds and Canceling Special Accounts for Raised Funds
May 16, 2024
Announcement on Resolutions of 12th Session of 2nd Board of Directors
April 29, 2024